Patients with noninsulin-dependent diabetes mellitus (NIDDM) have both preprandial and postprandial hyperglycemia. To determine the mechanism responsible for the postprandial hyperglycemia, insulin secretion, insulin action, and the pattern of carbohydrate metabolism after glucose ingestion were assessed in patients with NIDDM and in matched nondiabetic subjects using the dual isotope and forearm catheterization techniques. Prior to meal ingestion, hepatic glucose release was increased (P less than 0.001) in the diabetic patients measured using [2-3H] or [3-3H] glucose. After meal ingestion, patients with NIDDM had excessive rates of systemic glucose entry (1,316 +/-56 vs. 1,018 +/-65 mg/kg X 7 h, P less than 0.01), primarily owing to a failure to suppress adequately endogenous glucose release (680 +/-50 vs. 470 +/-32 mg/kg X 7 h, P less than 0.01) from its high preprandial level. Despite impaired suppression of endogenous glucose production during a hyperinsulinemic glucose clamp (P less than 0.001) and decreased postprandial Cpeptide response (P less than 0.05) in NIDDM, percent suppression of hepatic glucose release after oral glucose was comparable in the diabetic and nondiabetic subjects (45 +/-3 vs. 39 +/-2%). Although new glucose formation from meal-derived three-carbon precursors (53 +/-3 vs. 40 +/-7 mg/kg X 7 h, P less than 0.05) was greater in the diabetic patients, it accounted for only a (1,316±56 vs. 1,018±65 mg/kg 7 h, P < 0.01), primarily owing to a failure to suppress adequately endogenous glucose release (680±50 vs. 470±32 mg/kg-7 h, P < 0.01) from its high preprandial level. Despite impaired suppression of endogenous glucose production during a hyperinsulinemic glucose clamp (P < 0.001) and decreased postprandial C-peptide response (P <0.05) in NIDDM, percent suppression of hepatic glucose release after oral glucose was comparable in the diabetic and nondiabetic subjects (45±3 vs. 39±2%). Although new glucose formation from meal-derived three-carbon precursors (53±3 vs. 40±7 mg/kg 7 h, P < 0.05) was greater in the diabetic patients, it accounted for only a minor part of this excessive postprandial hepatic glucose release. Postprandial hyperglycemia was exacerbated by the lack of an appropriate increase in glucose uptake whether measured isotopically or by forearm glucose uptake. Thus as has been proposed for fasting hyperglycemia, excessive hepatic glucose release and impaired glucose uptake are involved in the pathogenesis of postprandial hyperglycemia in patients with NIDDM.
Introduction
After ingestion of glucose both hepatic and extrahepatic tissues participate in the maintenance ofnormal carbohydrate tolerance. In nondiabetic humans, the liver minimizes postprandial hyperglycemia both by increasing glucose uptake and by suppressing endogenous glucose production (1) (2) (3) . Although 90-100% ofthe ingested glucose initially reaches the peripheral circulation (2, 3) , -30-35% is eventually cleared by the liver (4, 5) . Recent studies have emphasized that hepatic glycogen formation may occur both by direct uptake of glucose or by synthesis of new Address reprint requests to Dr. Rizza. Receivedfor publication 16 July 1985 and in revisedform 15 January 1986. glucose from three-carbon precursors (6) (7) (8) . Postprandial suppression of endogenous glucose production can prevent an additional 25-35 g of glucose from entering the systemic circulation (2, 3) . These processes presumably are orchestrated by both insulin-and glucose-induced modulation of glucose production and utilization.
Patients with noninsulin-dependent diabetes mellitus (NIDDM)' are hyperglycemic both prior to and after meal ingestion. A variety of studies have suggested that after an overnight fast, hyperglycemia is due to overproduction of glucose (9) (10) (11) (12) . These abnormalities presumably result from both insulin resistance (13) (14) (15) (16) as well as a failure ofcompensatory pancreatic insulin secretion (17) . In contrast to preprandial hyperglycemia, the mechanisms responsible for postprandial hyperglycemia are unknown. Felig et al. (18) , using the hepatic catheter technique, suggested that postprandial glucose intolerance in patients with NIDDM was due to impaired hepatic uptake ofingested glucose. This conclusion, however, was based on the assumption that endogenous glucose production remained constant in both diabetic and nondiabetic humans. Although this assumption has subsequently been shown to be erroneous in nondiabetic man (2, 3) , there exist no data examining the relative contributions of meal-related and endogenous glucose release to postprandial carbohydrate intolerance. Previous studies in patients with insulin-dependent diabetes mellitus demonstrated that the primary cause of postprandial hyperglycemia was the failure of the liver to decrease endogenous glucose release appropriately (3) . Whether a similar defect is present in patients with NIDDM who have residual insulin secretion and therefore can increase portal venous insulin concentrations is unknown. Although it is well established that gluconeogenesis is increased in NIDDM patients in the postabsorptive state (19) (20) (21) , there are no data determining whether the rate of new glucose formation from meal-derived three-carbon precursors is increased after meal ingestion. Finally, in addition to uncertainty regarding the pattern of postprandial hepatic glucose release, the contribution of alterations in glucose uptake by extrahepatic tissues to impaired postprandial meal disposition in NIDDM also is unknown. The current studies were, therefore, undertaken to address each of these issues. We sought to determine (a) whether postprandial hyperglycemia is due to excessive glucose entry or decreased glucose utilization, (b) if excessive postprandial glucose entry occurs, whether this is due to a failure to suppress endogenous glucose production adequately and/or to increased rates ofsystemic meal glucose appearance, (c) whether systemic entry ofglucose formed from meal-derived three-carbon precursors is increased, (d) whether alterations in total body glucose utilization are accompanied by alterations in extrahepatic insulin-sensitive tissues as exemplified by the forearm, and (e) whether the ab-normal pattern ofpostprandial glucose metabolism is associated with abnormalities in insulin secretion and/or action.
Methods
All studies were performed in the Clinical Research Center using protocols approved by the Mayo Clinic Institutional Review Board. Informed, written consent was obtained from 13 noninsulin-dependent diabetic patients and seven nondiabetic subjects (Table I ). All subjects were otherwise healthy. Of the 13 diabetic patients, nine were being managed with diet alone, and four were receiving sulfonylureas in addition. Sulfonylureas were discontinued at least 3 wk prior to study. All volunteers consumed a stable diet including at least 200 g of carbohydrate for the 3 d preceding study. Meal studies were performed first on all individuals followed I wk later by the hyperinsulinemic glucose clamp studies, except for one diabetic subject in whom this order was reversed. All studies were commenced after an overnight fast, the patients having consumed only water for the previous 12-14 h.
Meal study. On the morning of study, a large antecubital vein was cannulated with an 18-gauge plastic cannula (Cathlon IV, Criticon, Inc., Tampa, FL) for administration of [2-3H]glucose tracer. A 19-gauge butterfly needle (Terumo Corp., Tokyo, Japan) was inserted in a dorsal vein of the ipsilateral hand which was maintained at 550C for intermittent sampling of arterialized blood as previously described (22, 23) . A second 18-gauge cannula was inserted in retrograde fashion into a large, deep antecubital vein of the contralateral arm for intermittent sampling of deep venous forearm blood (24) . An electrocapacitance plethysomography cuff (UFI, Morro Bay, CA) was applied just distal to the tip of this cannula for measurement of forearm blood flow by the method of Figar (25) as modified by Hyman et al. (26) . The venous occlusion cuff was fitted to the upper arm and a high pressure wrist cuff inflated to 300 mmHg to isolate the hand vasculature 3 min prior to blood flow measurement and deep venous sampling.
A primed (13.8 ,uCi) continuous (0.138 gCi/min) infusion of [2- 3H]glucose (New England Nuclear, Boston, MA; sp act 14 Ci/mmol) was commenced between 0700 and 0800 hours for isotopic determination of total rates of glucose appearance and uptake. After a 2-h equilibration period, each subject ingested 50 g of glucose labeled with 100 tCi [6- 4C]glucose (New England Nuclear; sp act 9.5 Ci/mmol) dissolved in 100 ml of artificially flavored water. Two subsequent water rinses of the flask were also ingested, after which <0.01% of the original radioactivity remained in the flask.
Forearm blood flow measurement and simultaneous blood sampling from the arterialized and deep venous sites were performed 30, 20, 10, and 0 min before and 15, 30, 45, 60, 90, 120, 180, 240, 300, 360 , and 420 min after glucose ingestion. Blood samples were immediately placed on ice, centrifuged at 4°C, and separated for storage at -20°C until assayed.
Blood for the determination of glucose specific activities and 14C randomization was deproteinized by the method of Somogyi (27) and purified by sequential passage over anion (AGI-X8, Bio-Rad Laboratories, Richmond, CA) and cation (AG5OW, Bio-Rad Laboratories) exchange columns to remove charged intermediary metabolites. The eluate was then evaporated to dryness under nitrogen and reconstituted in phosphate buffer, pH 7.4. Plasma insulin, C peptide, and glucagon were determined by radioimmunoassay as previously described (28) (29) (30) (31, 32) . Subtraction of RR. from '4CRa yields the rate of appearance of noncatabolized [6-'4Cjglucose derived directly from the meal (mealderived glucose). Forearm glucose uptake was obtained from the product of the forearm blood flow and the arteriovenous difference in whole blood glucose concentration. The latter is derived as follows: whole blood glucose concentration = plasma glucose concentration X (1-0.3 hematocrit) (37) .
Modified meal study. To determine the extent to which futile cycling at the level of glucose/glucose-6-phosphate and/or cycling of glucose through glycogen influenced the results in the diabetic patients, three patients were restudied using an experimental design identical to the original meal study with the exception that a primed-continuous infusion of both [2-3H] glucose and [3-3H] glucose was commenced between 0700 and 0800 hours. Total glucose appearance, systemic appearance ofmealderived glucose, endogenous glucose release, and new glucose appearance from meal derived three-carbon precursors were traced separately using each isotope. Forearm glucose uptake was not measured in these subjects.
Blood for determination of[2-3H]-and [3-3H1glucose specific activity was deproteinized and passed over anion and cation exchange columns as described above. After drying, one aliquot was used for determination of total '4C and total 3H counts. After addition of 0.5 ml of 133 mM phosphate buffer and 10 ml of Safety-Solve (Research Products International Corp., Mount Prospect, IL), this 0.25-ml aliquot was counted in a dual-channel refrigerated liquid scintillation spectrometer. The external ratios method was used to correct for quenching. Radioactivity in this aliquot represented total '4C and total 3H (both 2-3H and 3-3H radioactivity). The second 0.25-ml aliquot was used for determination of [3- 3Hlglucose radioactivity. This was accomplished by selective enzymatic detritiation of [2-3H] glucose during which [3-3H] glucose was left intact (38) . Subtraction of the [3-3HJglucose radioactivity from total tritiated radioactivity yielded [2-3H] glucose radioactivity. Selective detritiation of [2-3H]glucose was performed using a modification of the method of Issekutz (38) . 0.5 ml ofa mixture containing 1.2 U of hexokinase (Sigma Chemical Co.), 5 U ofphosphoglucose isomerase (Sigma Chemical Co.), MgCl2 (final concentration in reaction mixture 6 mM), and ATP (Sigma Chemical Co., final concentration 5.6 mM) was added to a 0.25-ml aliquot of reconstituted plasma. The mixture was incubated at 370C for 2 h.
The samples were then dried under a stream of air, reconstituted in water, and counted as above.
External standards of [3-3Hlglucose and [2-3HJglucose in patient plasma were processed in parallel with every patient assay. The results were used to calculate the degree of detritiation of each isotope during each patient assay. Overall completion of detritiation of [2-3Hjglucose was 96.5±0.3, (interassay CV 1.63%, intra-assay CV 0.9%) while 98.7±0.6 (interassay CV 2.6%, intra-assay CV 2.3%) of [3-3H] [3-3H] glucose (New England Nuclear, sp act 13.5 Ci/mmol) was commenced between 0700 and 0800 hours through an 18 gauge antecubital intravenous cannula (Cathlon IV). After a 2-h equilibration period, a primed-(4 mU/kg) continuous (0.4 mU/kg. min) infusion of semisynthetic regular human insulin (Actrapid, Squibb Novo Industries, Princeton, NJ) in 0.9% saline containing 1% human serum albumin (Cutter Laboratories, Berkeley, CA) was administered for a further 3 h in both diabetic and nondiabetic subjects. Plasma glucose was allowed to decrease in the diabetic patients until it reached euglycemic levels where it was maintained in both groups by an exogenous infusion of 50% dextrose as previously described (23) .
Arterialized blood was obtained through a butterfly needle (Terumo Corp.) lying retrograde in a dorsal vein of the contralateral hand which was maintained at 55°C. Samples for glucose specific activity were obtained during the final 30 min prior to and during the insulin infusion (23) and at half-hourly periods throughout the study for determination ofinsulin (28), C peptide (29) , glucagon (30) 
Results
Meal study Plasma glucose, insulin, Cpeptide, and glucagon concentrations (Fig. 1) . Prior to carbohydrate ingestion, the plasma glucose concentration was greater in the diabetic patients than in the nondiabetic subjects (187±11 vs. 98±3 mg/dl; P < 0.001). After carbohydrate ingestion both the peak plasma glucose concentration (280±12 vs. 149±5 mg/dl; P < 0.001) and glycemic excursion (95±8 vs. 51±5 mg/dl; P < 0.001) were greater and remained above preprandial levels longer (313±19 vs. 219±28 min; P < 0.02) in the diabetic patients than in the nondiabetic subjects. This resulted in a greater integrated glucose response above baseline in the diabetic patients (14,850±2,067 vs. 6,118±1,174 min * mg/dl; P < 0.002). Plasma insulin concentration did not differ significantly either prior to (14±2 vs. 11±5 MU/ml) or during the 7 h after meal ingestion in the diabetic and nondiabetic subjects, respectively. Neither plasma C peptide concentration (2.1±0.2 vs. 2.2±0.6 ng/ml) prior to nor integrated responses during the 7 h after meal ingestion (1,192±137 vs. 1,495±280 ng/ml * 7 h) differed significantly in the diabetic and nondiabetic subjects. However, the integrated C-peptide response above baseline was less in the former (340±74 vs. 613±65 min -ng/ml; P < 0.05). Plasma glucagon concentration was similar in both groups throughout the study.
Total glucose appearance and uptake (Fig. 2) . In the postabsorptive state, glucose appearance rates were greater in the diabetic patients than in nondiabetic subjects whether deter- mg/kg. min; P < 0.00 1) and during the 7 h after meal ingestion
(1,351±56 vs. 1,023±64 mg/kg. 7 h, P <0.01) were also greater in the diabetic patients. However, the integrated response above basal was significantly less in the diabetic patients (122±32 vs. 236±45 mg/kg, P < 0.05).
Meal-derived, endogenous, and new glucose appearancefrom meal-derived three-carbon precursors (Fig. 3) . The amount of meal-derived glucose reaching the systemic circulation over the 7-h observation period was slightly greater (622±19 vs. 521± 15 mg/kg; P < 0.02) in the diabetic patients, primarily owing to a greater rate of entry during the first 2 h (259±22 vs. 194±27 mg/kg, P = 0.08). Figure 3 . Rates of systemic appearance of meal-derived glucose, endogenous glucose production, and new glucose synthesized from mealderived three-carbon intermediates (arrow indicates glucose ingestion).
After meal ingestion, endogenous glucose production decreased in the nondiabetic subjects to a nadir of 0.9±0.1 mg/ kg min at 90 min, increasing to 1.5±0.1 mg/kg min at 420 min (P < 0.005 vs. 90 min). In contrast, the nadir in endogenous glucose production in diabetic patients did not occur until 300 min (1.3±0.1 mg/kg min) with glucose production increasing only minimally thereafter to 1.6±0.1 mg/kg-min at 420 min (P < 0.06 vs. 180 min). Percent suppression below basal was similar in both groups (45±3 vs. 39±2%). However, owing to the higher basal rates, total endogenous glucose release over the 7 h after meal ingestion was greater in the diabetic patients (680±50 vs. 470±32 mg/kg-7 h, P < 0.01).
New glucose appearance from meal-derived three-carbon precursors increased progressively throughout the 7- (Fig. 4) To determine the extent to which the rsults in the diabetic patients were influenced by the use of [2-3H1glucose to trace systemic glucose appearance, three diabetic patients were restudied. Experimental conditions were identical to those of the initial meal study with the exception that systemic glucose appearance was traced using a simultaneous infusion of both [ 4 .6±0.7 ml/dl forearm-min) meal ingestion. Forearm glucose uptake prior to meal ingestion was greater in the diabetic than nondiabetic subjects (0.26+0.04 vs. 0.14±0.02 mg/ dl forearm -min, P < 0.02). Over the 7 h after meal ingestion, forearm glucose uptake was slightly but not significantly higher in the diabetic patients (127±22 vs. 106±11 mg/dl forearm* 7 h). However, the integrated increase in forearm glucose uptake above basal tended to be less in the diabetic than nondiabetic subjects (48±12 vs. 55±8 mg/dl forearm). Effects ofinsulin on glucoseproduction andglucose utilization (hyperinsulinemic clamp) (Fig. 6) . Because glucose and insulin concentrations varied after meal ingestion in both diabetic and nondiabetic subjects, an accurate assessment of insulin action is difficult. Therefore the ability of insulin to suppress glucose production and stimulate glucose utilization was assessed in the same individuals on a separate day using the hyperinsulinemic glucose clamp technique. Plasma glucose concentration averaged (2, 3, 5, 32) . The current studies demonstrate that postprandial suppression of endogenous glucose production also occurs in patients with NIDDM. The magnitude of this suppression, measured as the percent change from preprandial rates, is equivalent to that observed in nondiabetic subjects. Howver, because the basal rates of glucose production are greater in the diabetic patients, the total amount of glucose released from the liver after meal ingestion also is greater whether calculated as release over the 7 h of observation or as release during the interval that plasma glucose remained above preprandial levels. This results in excessive amounts of glucose being presented to extrahepatic tissues for disposal. In that disposal does not increase appropriately, hyperglycemia ensued.
The pattern of suppression of glucose release also differed in the diabetic and nondiabetic subjects. Coincident with the rapid increase in insulin secretion, suppression of endogenous glucose release was prompt and sustained between 90 and 240 min in the nondiabetic subjects. Subsequently, as the plasma glucose concentration fell toward preprandial levels, endogenous glucose release increased towards basal rates, presumably reflecting postprandial counterregulation (41) . In contrast in the diabetic patients, glucose production after meal ingestion decreased slowly and progressively, for 5 h. This excessive endogenous glucose production could not be attributed to excessive circulating glucagon concentrations in the NIDDM patients.
Both decreased insulin secretion (as reflected by lower insulin and C peptide concentrations) and decreased insulin action (as reflected by impaired suppression of glucose production during the euglycemic clamp) presumably contributed to the excessive postprandial endogenous glucose release in the diabetic patients. However, because the portal insulin and plasma glucose concentrations differed during the hyperinsulinemic clamp and after glucose ingestion, the quantitative contribution of alterations in insulin secretion and insulin action cannot be determined. Of interest, the pattern of suppression ofendogenous glucose release observed in the current study ofpatients with NIDDM is similar to that previously reported in C peptide-deficient patients with insulin-dependent diabetes mellitus (3).
Several investigators have reported that gluconeogenesis is increased in patients with NIDDM in the postabsorptive state (19) (20) (21) . Furthermore, recent data indicate that a substantial portion of the glycogen synthesized after glucose ingestion originates via the indirect pathway entailing gluconeogenesis from three-carbon precursors rather than from direct hepatic uptake of glucose (7, 42 (44) have suggested a correction factor of approximately 2.2 for dilution of labeled by unlabeled precursors in the oxaloacetate pool during gluconeogenesis. Because this correction factor has only been validated in postabsorptive animals under steady-state conditions, its applicability to humans after meal ingestion remains uncertain. Nevertheless, even invoking such a correction factor, new glucose formation from meal-derived three-carbon precursors still represents a small fraction of total endogenous glucose release in either the diabetic or nondiabetic subjects.
After carbohydrate ingestion, virtually all ofthe meal-derived glucose eventually reached the systemic circulation over the 7-h study period in the diabetic and nondiabetic subjects. This finding in the nondiabetic subjects is consistent with previous reports (2, 3) . However, the amount of meal glucose reaching the systemic circulation during the period of postprandial hyperglycemia was slightly but significantly greater in the diabetic than nondiabetic subjects (622±19 vs. 521 ± 15 mg/kg min or -46 vs. 52 g). These results suggest negligible initial hepatic uptake in the diabetic patients compared to -8% in the nondiabetic patients. The estimate in nondiabetic subjects is consistent with that of previous investigators (2, 3) . However, as discussed by Radzuik et al. (2) , assuming that recirculating glucose and meal derived glucose are present in the portal vein in a ratio of 5:1, an initial hepatic clearance of 4 g more of meal glucose is consistent with a 20-g greater total hepatic glucose uptake in the nondiabetic than diabetic patients. However, this estimate must be tempered by the fact that the ['4C]glucose used to label the meal could be incorporated into and released from glycogen during the long postabsorptive period. Such "cycling" through glycogen would lead to an underestimate of first-pass hepatic glucose clearance.
The potential influence of the choice of isotope of glucose employed to trace the systemic entry of glucose on the measurements of glucose flux rate in the diabetic patients must be considered. In the dual isotope technique the same isotope is used to estimate the total and meal-derived systemic glucose appearance. Therefore any error inherent in the systemic tracer wil be introduced into measurement ofboth of these parameters. There is less concern regarding estimates ofendogenous glucose because it is calculated by subtracting the meal-derived from the total appearance rate. [2-3H]glucose was used to trace the rate of systemic glucose appearance in the current study. This isotope was chosen because it does not retain its label during uptake and release of glucose from glycogen (45) . However, it possesses the disadvantage that it can be detritiated during flux between glucose-6-phosphate and fructose-6-phosphate, a process frequently referred to as futile cycling. Although alternative isotopes such as [3-3H] glucose, [6-3H] glucose, and [6-'4C]glucose are not detritiated in the glucose/glucose-6-phosphate cycle, they can be incorporated into and released from glycogen without losing their radioactive label. If this process is active, the latter isotopes will result in an underestimate of both glucose appearance and disappearance. This may be a particular problem in the postprandial state because the outer layers of glycogen may be preferentially labeled at a time when glycogen synthesis and glycogenolysis are occurring simultaneously (46) .
In the current study, the greater postprandial endogenous glucose release in the diabetic patients could be entirely ascribed to the greater basal glucose production rate in the diabetic patients. Preprandial production rates determined with [2-3H]glucose were greater than those determined with [3-3H] glucose in both diabetic and nondiabetic subjects indicating the presence of futile cycling, consistent with the report ofEfendic et al. (47) . However, the greater preprandial glucose production rates in the diabetic patients than in nondiabetic subjects were not due to glucose/glucose-6-phosphate cycling because it was documented independently with both [2-3H]-and [3-3H] glucose. Postprandial glucose turnover rates determined with [2-3H]-and [3-3H]glucose were essentially the same in the diabetic patients restudied using a simultaneous infusion ofboth isotopes. These studies suggest that both futile cycling and cycling through glycogen were minimal in the diabetic patients after carbohydrate ingestion.
In addition to excessive rates ofpostprandial systemic glucose entry, a lack of an appropriate postprandial increase in glucose uptake was evident in the diabetic patients. Thus, there was a smaller incremental response above basal in both total body (isotopically determined) and forearm glucose uptake. On the one hand, the demonstration by the hyperinsulinemic clamp study that glucose uptake, at insulin concentrations similar to those present after meal ingestion, was decreased in the diabetic subjects suggests that insulin resistance contributed to the impaired postprandial glucose disposal. On the other hand the failure of an appropriate increase in insulin secretion as indicated by the blunted C-peptide response above baseline was also clearly evident in the diabetic patients. Whether impaired glucose mediated uptake by both insulin-dependent and noninsulin-dependent tissues was also present cannot be assessed from the current experiments.
In contrast to the decreased incremental response in glucose uptake, the absolute rate ofglucose uptake measured either isotopically or by forearm catheterization (48) after meal ingestion was not decreased in the diabetic patients. Of interest, the magnitude of differences in glucose uptake between the diabetic and nondiabetic subjects differed when assessed isotopically or by forearm catheterization. This discrepancy may reflect the pattern of intracellular metabolism of the [2-3H] glucose. Glucose uptake measured with [2-3H] glucose primarily assesses transport and phosphorylation (47) whereas glucose uptake measured with forearm catheterization reflects irreversible glucose extraction. The similar postprandial rates of glucose utilization measured with [2-3H] and [3-3H] glucose (an isotope of glucose that is not detritiated in the glucose/glucose-6-phosphate cycle) in the diabetic patients studied with both isotopes argue against futile cycling as an explanation. The cause for the quantitative differences in the isotopic and forearm data are unknown. In contrast to the postprandial state, glucose uptake in the preprandial state (measured in all subjects) not only was higher when assessed with both [2-3H] glucose and [3-3H] glucose but also when measured by forearm glucose catheterization. The observation of increased rates of glucose utilization in the hyperglycemic patients, is consistent with the suggestion that the mass action effect of glucose on glucose uptake compensates for the presence of insulin resistance and/or insulin deficiency (12) .
In summary, the current studies demonstrate that the proximal cause of postprandial hyperglycemia in patients with NIDDM is an excessive rate of systemic glucose appearance. Despite the presence ofhepatic insulin resistance and decreased insulin secretion, percent suppression of hepatic glucose production is comparable in diabetic and nondiabetic subjects, presumably owing to the compensatory effect of hyperglycemia in the former. However, because preprandial rates are greater, the absolute rate of endogenous glucose release is excessive in diabetic patients after carbohydrate ingestion. Only a minor part of this excessive release can be accounted for by new glucose formation from three-carbon precursors. Postprandial hyperglycemia is further exacerbated by a lack of an appropriate increase in glucose uptake in diabetic patients. Thus, as has been proposed for fasting hyperglycemia, excessive hepatic glucose release and impaired glucose uptake plays a central role in production ofpostprandial hyperglycemia in patients with NIDDM.
